Meta Health (SGX:5DX) received a listing and quotation notice from the SGX for listing 23,331,000 consideration shares as part of its acquisition of Jas Medical Screening, a filing with the Singapore Exchange on Wednesday.
The LQN also includes the listing and quotation of 15,554,000 earn-out shares to be issued to Lek. Under the revised terms, earn-out shares will be issued if Jas Medical achieves net profits of at least SG$175,000 in 2025 and 2026, with adjustments linked to changes in Meta's share base.
Meanwhile up to 2,755,400 shares have been allotted as introducer shares.
In an earlier filing, the company had entered into a sale and purchase agreement with Lian Ah Lek to acquire a 55% stake in Jas Medical Screening Centre for SG$533,310.
Of the total consideration, SG$300,000 was payable in cash while 23,331,100 Meta shares were to be allotted and issued to the vendor at an issue price of SG$0.01 apiece, against a 55% stake in the medical screening company.
Shares of the medical services company crashed over 14% in recent trading.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。